Xenon Pharmaceuticals (XENE) EBT Margin Growth (1y) (2014 - 2022)
Xenon Pharmaceuticals (XENE) EBT Margin Growth (1y) (2014 - 2022) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
EBT Margin Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-1,532.00 |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
1,558.00 |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Xenon Pharmaceuticals |
4.61 Bn |
4.61 Bn |
- |
- |
| Date | Value |
|---|
| Sep 30, 2022 |
-2.82 Mn |
| Jun 30, 2022 |
-481,394.00 |
| Mar 31, 2022 |
13,440.00 |
| Dec 31, 2021 |
-43,157.00 |
| Sep 30, 2021 |
-20,957.00 |
| Jun 30, 2021 |
-100,498.00 |
| Mar 31, 2021 |
-25,754.00 |
| Dec 31, 2020 |
10,325.00 |
| Sep 30, 2020 |
11,511.00 |
| Dec 31, 2017 |
-4.83 Mn |
| Sep 30, 2017 |
-147,982.00 |
| Jun 30, 2017 |
-5.04 Mn |
| Mar 31, 2017 |
-4.81 Mn |
| Dec 31, 2016 |
-133,032.00 |
| Sep 30, 2016 |
-173,139.00 |
| Jun 30, 2016 |
-152,057.00 |
| Mar 31, 2016 |
-77,571.00 |
| Dec 31, 2015 |
-8,149.00 |
| Sep 30, 2015 |
-8,276.00 |
| Jun 30, 2015 |
-1,965.00 |
